Deze vertaling wordt voorbereid. Voorlopig tonen we de oorspronkelijke Engelse versie.
Bedrijven · 6-10-20211 min lezen
Issuance of Priority Review Voucher; Rare Pediatric Disease Product; Withdrawal
Lokale automatische vertaling · Oorspronkelijke brontaal
Samenvatting
The Food and Drug Administration (FDA) is withdrawing the notice that published in the Federal Register of September 30, 2021, that announced the issuance of a priority review voucher to the sponsor of a rare pediatric disease product application. The Federal Register notice was published in error and is being withdrawn.
Oorspronkelijke brontaal: Federal Register — Food and Drug AdministrationOrigineel bericht openen →